PathGroup, one of the largest providers of anatomical pathology, digital pathology, clinical and molecular laboratory services in the United States, has acquired DermLab.
DermLab is an independent dermatopathology laboratory based in Birmingham, Alabama. The addition of DermLab is PathGroup’s second dermatology acquisition in 2021 and enhances the company’s dermatopathology capabilities, a key strategic initiative.
Building on previous acquisitions of Atlanta Dermatopathology and SkinDx, DermLab’s capabilities significantly extend PathGroup’s presence in dermatopathology and strengthen its position in the south-eastern USA. The combination allows existing DermLab clients to access PathGroup’s state-of-the-art molecular and clinical pathology services. Together, PathGroup and DermLab will provide physicians and patients with leading dermatopathology, digital pathology and clinical services.
“We are pleased to welcome DermLab’s talented pathologists to the growing PathGroup family of nearly 200 pathologists,” said Dr Ben W Davis, President and Chief Executive Officer of PathGroup. “As PathGroup continues to expand our dermatopathology capabilities, we will be guided by our commitment to physician leadership, diagnostic excellence and high-quality patient services.”
